Select Page
FDA Approves Thermo Fisher’s CDx Cancer Tissue Test

FDA Approves Thermo Fisher’s CDx Cancer Tissue Test

The U.S. Food and Drug Administration (FDA) has granted premarket approval for Thermo Fisher’s Oncomine Dx Target Test as a companion diagnostic (CDx) developed to help identify non-small cell lung cancer (NSCLC) patients. Lung cancer is the leading cause of...
Women Lead The Way For CSOFT Health Sciences

Women Lead The Way For CSOFT Health Sciences

Interviewing CSOFT Health Sciences Strategy Advisor, Amgen VP for JAPAC, Professor Victoria Elegant; CSOFT Health Sciences SVP, Strategic Partnerships & Medical Writing, Dr. Nimita Limaye; and CSOFT Founder & CEO, Shunee Yee In celebration of International...